Clinical Trial Update: Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates the safety of accelerated infusions of infliximab in patients with inflammatory bowel disease, including Crohn's disease and ulcera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Asan Medical Center | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 4 | Status: COMPLETED